2021
DOI: 10.3389/fneur.2021.746404
|View full text |Cite
|
Sign up to set email alerts
|

Discrete-Event Simulation to Model the Thrombolysis Process for Acute Ischemic Stroke Patients at Urban and Rural Hospitals

Abstract: Background: Effective treatment with tissue plasminogen activator (tPA) critically relies on rapid treatment. Door-to-needle time (DNT) is a key measure of hospital efficiency linked to patient outcomes. Numerous changes can reduce DNT, but they are difficult to trial and implement. Discrete-event simulation (DES) provides a way to model and determine the impact of process improvements.Methods: A conceptual framework was developed to illustrate the thrombolysis process; allowing for treatment processes to be r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 46 publications
0
2
0
Order By: Relevance
“…For example, a discrete-event simulation for a door to treatment process includes the distribution of treatment times for each process step; different change strategies are run to determine the effect on treatment times. 3 System dynamic simulation modeling is used to determine larger policy effects on incidence of stroke and other diseases. 5 Allen et al uses a Monte Carlo simulation technique to model a simple 4-step process from onset to the start of thrombolysis and then uses clinical trial data to determine patient outcomes.…”
Section: See Related Article P 2758mentioning
confidence: 99%
See 1 more Smart Citation
“…For example, a discrete-event simulation for a door to treatment process includes the distribution of treatment times for each process step; different change strategies are run to determine the effect on treatment times. 3 System dynamic simulation modeling is used to determine larger policy effects on incidence of stroke and other diseases. 5 Allen et al uses a Monte Carlo simulation technique to model a simple 4-step process from onset to the start of thrombolysis and then uses clinical trial data to determine patient outcomes.…”
Section: See Related Article P 2758mentioning
confidence: 99%
“…Machine learning and computer simulation are relatively recent approaches to assess stroke systems of care through secondary use of data available in existing databases and registries. 1,2,3 Allen et al 4 use both approaches in their study on factors influencing thrombolysis rates across England and Wales. The goal of this study was to assess how much variation is due to differences in local patient populations, and how much is due to differences in clinical decision-making and stroke pathway performance.…”
mentioning
confidence: 99%